Medicus Pharma Ltd. -29MDCXWPreferred / convertible
13F holders, Q2 2026 (June 30)4holders −2
0new positions
2sold out
$0.57avg. 13F price*
At the end of Q2 2026, 4 institutions reported holding Medicus Pharma Ltd. -29 (MDCXW) in their 13F filings, down 2 from Q1 2026. 0 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($39K), Anson Funds Management LP ($19K) and Connective Capital Management, LLC ($4K).
- Company
- Medicus Pharma Ltd. -29
- CUSIP
- 58471K111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $39K |
All 13F filers, Q1 2026 → Q2 2026: 738 shares bought and 61,100 shares sold, net −60,362 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Armistice Capital, LLC | — | No change | 60,600 | $39K |
| Anson Funds Management LP | — | No change | 42,400 | $19K |
| Connective Capital Management, LLC | — | No change | 6,000 | $4K |
| UBS Group AG | — | Add +50.4% | 2,203 | $1K |
"% of holder's portfolio" is MDCXW's weight in each manager's 13F, not the share of Medicus Pharma Ltd. -29 the manager owns.